Flavin‐containing monooxygenase (FMO): Beyond xenobiotics
BioEssays · 2024-07 · 46 (7)
DOI: 10.1002/bies.202400029 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioEssays, online erschienen am 07.05.2024. Verfasst von Ajay Bhat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular & Integrative Physiology Department, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Xenobiotics, Caenorhabditis elegans, Oxygenases. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, Glenn Foundation for Medical Research, National Institute on Aging.
Abstract (Originalsprache)
Flavin‐containing monooxygenases (FMOs), traditionally known for detoxifying xenobiotics, are now recognized for their involvement in endogenous metabolism. We recently discovered that an isoform of FMO, fmo‐2 in Caenorhabditis elegans , alters endogenous metabolism to impact longevity and stress tolerance. Increased expression of fmo‐2 in C. elegans modifies the flux through the key pathway known as One Carbon Metabolism (OCM). This modified flux results in a decrease in the ratio of S‐adenosyl‐methionine (SAM) to S‐adenosyl‐homocysteine (SAH), consequently diminishing methylation capacity. Here we discuss how FMO‐2‐mediated formate production during tryptophan metabolism may serve as a trigger for changing the flux in OCM. We suggest formate bridges tryptophan and OCM, altering metabolic flux away from methylation during fmo‐2 overexpression. Additionally, we highlight how these metabolic results intersect with the mTOR and AMPK pathways, in addition to mitochondrial metabolism. In conclusion, the goal of this essay is to bring attention to the central role of FMO enzymes but lack of understanding of their mechanisms. We justify a call for a deeper understanding of FMO enzyme's role in metabolic rewiring through tryptophan/formate or other yet unidentified substrates. Additionally, we emphasize the identification of novel drugs and microbes to induce FMO activity and extend lifespan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular & Integrative Physiology Department, University of Michigan, Ann Arbor, Michigan, USA.
- Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Scott F Leiser
Förderung
- NIA NIH HHS
- Glenn Foundation for Medical Research
- National Institute on Aging
Zitieren
APA
Bhat, A., Carranza, F. R., Tuckowski, A. M., & Leiser, S. F. (2024). Flavin‐containing monooxygenase (FMO): Beyond xenobiotics. BioEssays, 46(7). https://doi.org/10.1002/bies.202400029
Vancouver
Bhat A, Carranza FR, Tuckowski AM, Leiser SF. Flavin‐containing monooxygenase (FMO): Beyond xenobiotics. BioEssays. 2024;46(7). doi:10.1002/bies.202400029
BibTeX
@article{Bhat2024,
author = {Bhat, Ajay and Carranza, Faith R and Tuckowski, Angela M and Leiser, Scott F},
title = {Flavin‐containing monooxygenase (FMO): Beyond xenobiotics},
journal = {BioEssays},
year = {2024},
volume = {46},
number = {7},
doi = {10.1002/bies.202400029}
}
EUVIMED